STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma

  • Authors:
    • Jinju Park
    • Woochan Lee
    • Sangil Yun
    • Saet Pyoul Kim
    • Kyung Hyun Kim
    • Jong‑Il Kim
    • Seung‑Ki Kim
    • Kyu‑Chang Wang
    • Ji Yeoun Lee
  • View Affiliations

  • Published online on: June 5, 2020     https://doi.org/10.3892/ol.2020.11699
  • Pages: 1989-1998
  • Copyright: © Park et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Diffuse intrinsic pontine glioma (DIPG) is one of the most lethal childhood brain tumors. This tumor is unique because it is detected exclusively in the ventral pons of patients aged between 6 and 7 years, which suggests a developmental nature of its formation. Signal transducer and activator of transcription 3 (STAT3) is a critical molecule for the differentiation of neural stem cells into astrocytes during neurodevelopment. Additionally, STAT3 is associated with oncogenesis and the epithelial‑mesenchymal transition (EMT) in various types of tumor. In recent years, several studies have demonstrated the oncogenic role of STAT3 in high‑grade gliomas. However, the role of STAT3 in DIPG at the cellular level remains unknown. To assess the possible association between gliogenesis and DIPG, the expression levels of various molecules participating in the differentiation of neural stem cells were compared between normal brain control tissues and DIPG tissues using open public data. All of the screened genes exhibited significantly increased expression in DIPG tissues compared with normal tissues. As STAT3 expression was the most increased, the effect of STAT3 inhibition in a DIPG cell line was assessed via STAT3 short hairpin (sh)RNA transfection and treatment with AG490, a STAT3 inhibitor. Changes in viability, apoptosis, EMT and radiation therapy efficiency were also evaluated. Downregulation of STAT3 resulted in decreased cyclin D1 expression and cell viability, migration and invasion. Additionally, treatment with STAT3 shRNA or AG490 suppressed the EMT phenotype. Finally, when radiation was administered in combination with STAT3 inhibition, the therapeutic efficiency, assessed by cell viability and DNA damage repair, was increased. The present results suggest that STAT3 is a potential therapeutic target in DIPG, especially when combined with radiation therapy.

Related Articles

Journal Cover

August-2020
Volume 20 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Park J, Lee W, Yun S, Kim S, Kim K, Kim JI, Kim SK, Wang KC and Lee J: STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma. Oncol Lett 20: 1989-1998, 2020
APA
Park, J., Lee, W., Yun, S., Kim, S., Kim, K., Kim, J. ... Lee, J. (2020). STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma. Oncology Letters, 20, 1989-1998. https://doi.org/10.3892/ol.2020.11699
MLA
Park, J., Lee, W., Yun, S., Kim, S., Kim, K., Kim, J., Kim, S., Wang, K., Lee, J."STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma". Oncology Letters 20.2 (2020): 1989-1998.
Chicago
Park, J., Lee, W., Yun, S., Kim, S., Kim, K., Kim, J., Kim, S., Wang, K., Lee, J."STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma". Oncology Letters 20, no. 2 (2020): 1989-1998. https://doi.org/10.3892/ol.2020.11699